Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

The real reason to be cautious about Z-Paks and azithromycin

Albert Fuchs, MD
Meds
April 10, 2013
Share
Tweet
Share

The FDA issued a warning about the antibiotic azithromycin (Zithromax). The media stories have some patients terrified and some of them are calling me convinced that azithromycin is poison, a reliable agent for suicide.

What’s the hubbub about?

Azithromycin is in a family of antibiotics called macrolides, which also includes erythromycin and clarithromycin (Biaxin). Erythromycin and clarithromycin have long been known to very rarely cause fatal abnormal heart rhythms. It was thought that azithromycin didn’t have this rare side effect.

In May of last year the New England Journal of Medicine published a study that tried to confirm this. The study compared rates of sudden death while taking a course of azithromycin to the risk while taking amoxicillin, ciprofloxacin, levofloxacin, or no antibiotic. The study was not randomized. It simply matched hundreds of thousands of antibiotic prescriptions to death certificates.

The study found a tiny increased risk in patients taking azithromycin. How tiny? Compared to taking amoxicillin, taking azithromycin contributed 47 additional cardiovascular deaths per 1 million antibiotic courses. That’s one extra death per 21,276 courses. If you took 5-day azithromycin courses continuously, it would take 291 years to take that many courses of antibiotics. That’s a much slower way to die than, say, hemlock.

All patients did not have the same risk of having a fatal heart rhythm abnormality. Older patients, patients taking medications for heart rhythm abnormalities, and patients with heart disease, certain EKG abnormalities, and certain electrolyte abnormalities were at greater risk of this side effect. The patients at highest risk face one additional death every 4,100 courses of antibiotics, while those at lowest risk have one additional death every 110,000. These are very, very small risks.

So doctors should try to avoid all macrolides in high risk patients. But patients should probably forget the whole thing and avoid azithromycin for a different reason.

The reason you should avoid azithromycin is the same as the reason you should avoid all antibiotics. The risk of Clostridium difficile infection and the risk of antibiotic resistance is much greater than the miniscule risk of a fatal rhythm abnormality. That’s what should be scaring you about antibiotics. This is especially true of azithromycin because its convenient 5-day course, the Z-Pak, has become a household name and patients ask for it even when antibiotics are very unlikely to help. It is very likely that the last Z-Pak you took was for a cold, or for acute bronchitis, or for an early sinus infection, all of which resolve without antibiotics.

It would be a sad irony if we needed the irrational fear of extremely rare side effects to counter the irrational exuberance that patients have for unnecessary antibiotics. I hope instead that educated patients armed with reliable information will make good decisions.

Albert Fuchs is an internal medicine physician who blogs at his self-titled site, Albert Fuchs, MD.

Prev

Medical educators: Take charge and help deflate medical bills

April 10, 2013 Kevin 1
…
Next

There is no such thing as minor anesthesia

April 10, 2013 Kevin 1
…

Tagged as: Infectious Disease, Medications, Primary Care

Post navigation

< Previous Post
Medical educators: Take charge and help deflate medical bills
Next Post >
There is no such thing as minor anesthesia

ADVERTISEMENT

More by Albert Fuchs, MD

  • Processed meats and cancer: How much is too much?

    Albert Fuchs, MD
  • This is the best way to treat chronic insomnia

    Albert Fuchs, MD
  • Paying people to quit smoking. Does it work?

    Albert Fuchs, MD

More in Meds

  • Testosterone cardiovascular risk: FDA update 2025

    Martina Ambardjieva, MD, PhD
  • Are you neurodivergent or just bored?

    Martha Rosenberg
  • Pharmacy benefit manager reform vs. direct drug plans

    Leah M. Howard, JD
  • A cautionary tale about pramipexole

    Anonymous
  • My persistent adverse reaction to an SSRI

    Scott McLean
  • Tofacitinib: a lesson in heart-immune health

    Larry Kaskel, MD
  • Most Popular

  • Past Week

    • The Silicon Valley primary care doctor shortage

      George F. Smith, MD | Physician
    • A lesson in empathy from a young patient

      Dr. Arshad Ashraf | Physician
    • Autism prevalence surveillance: a reckoning, not a crisis

      Ronald L. Lindsay, MD | Conditions
    • Physician income vs. burnout: Why working harder fails

      Jerina Gani, MD, MPH | Physician
    • The human element in clinical trials

      Dr. Bodhibrata Banerjee | Physician
    • Our relationship with medicine: a triumph

      Joseph Shaw | Conditions
  • Past 6 Months

    • Why you should get your Lp(a) tested

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • Rebuilding the backbone of health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • Direct primary care in low-income markets

      Dana Y. Lujan, MBA | Policy
    • The flaw in the ACA’s physician ownership ban

      Luis Tumialán, MD | Policy
    • Systematic neglect of mental health

      Ronke Lawal | Tech
    • Stop doing peer reviews for free

      Vijay Rajput, MD | Education
  • Recent Posts

    • Why your midlife choices will define your future health [PODCAST]

      The Podcast by KevinMD | Podcast
    • Testosterone cardiovascular risk: FDA update 2025

      Martina Ambardjieva, MD, PhD | Meds
    • Alcohol, dairy, and breast cancer risk

      Neal Barnard, MD | Conditions
    • The erosion of evidence-based medicine: a doctor’s warning

      Corinne Sundar Rao, MD | Physician
    • Infertility public health: the WHO’s new global guideline

      Oluyemisi Famuyiwa, MD | Conditions
    • Imposter syndrome: a poem of self-talk

      Mary Remón, LCPC | Conditions

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 1 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • The Silicon Valley primary care doctor shortage

      George F. Smith, MD | Physician
    • A lesson in empathy from a young patient

      Dr. Arshad Ashraf | Physician
    • Autism prevalence surveillance: a reckoning, not a crisis

      Ronald L. Lindsay, MD | Conditions
    • Physician income vs. burnout: Why working harder fails

      Jerina Gani, MD, MPH | Physician
    • The human element in clinical trials

      Dr. Bodhibrata Banerjee | Physician
    • Our relationship with medicine: a triumph

      Joseph Shaw | Conditions
  • Past 6 Months

    • Why you should get your Lp(a) tested

      Monzur Morshed, MD and Kaysan Morshed | Conditions
    • Rebuilding the backbone of health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • Direct primary care in low-income markets

      Dana Y. Lujan, MBA | Policy
    • The flaw in the ACA’s physician ownership ban

      Luis Tumialán, MD | Policy
    • Systematic neglect of mental health

      Ronke Lawal | Tech
    • Stop doing peer reviews for free

      Vijay Rajput, MD | Education
  • Recent Posts

    • Why your midlife choices will define your future health [PODCAST]

      The Podcast by KevinMD | Podcast
    • Testosterone cardiovascular risk: FDA update 2025

      Martina Ambardjieva, MD, PhD | Meds
    • Alcohol, dairy, and breast cancer risk

      Neal Barnard, MD | Conditions
    • The erosion of evidence-based medicine: a doctor’s warning

      Corinne Sundar Rao, MD | Physician
    • Infertility public health: the WHO’s new global guideline

      Oluyemisi Famuyiwa, MD | Conditions
    • Imposter syndrome: a poem of self-talk

      Mary Remón, LCPC | Conditions

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

The real reason to be cautious about Z-Paks and azithromycin
1 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...